These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
525 related items for PubMed ID: 18414197
1. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility. Chen HC, Hu WX, Liu QX, Li WK, Chen FZ, Rao ZZ, Liu XF, Luo YP, Cao YF. Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197 [Abstract] [Full Text] [Related]
3. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, Ozbek U. Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615 [Abstract] [Full Text] [Related]
6. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia. Balta G, Yuksek N, Ozyurek E, Ertem U, Hicsonmez G, Altay C, Gurgey A. Am J Hematol; 2003 Jul; 73(3):154-60. PubMed ID: 12827651 [Abstract] [Full Text] [Related]
9. Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia. Bajpai P, Tripathi AK, Agrawal D. Leuk Res; 2007 Oct; 31(10):1359-63. PubMed ID: 17420047 [Abstract] [Full Text] [Related]
10. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer]. Fan CH, Jin MJ, Zhang Y, Song L, Xu H, Jiang QT, Yu WP, Chen K. Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591 [Abstract] [Full Text] [Related]
11. Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility. Luo YP, Chen HC, Khan MA, Chen FZ, Wan XX, Tan B, Ou-Yang FD, Zhang DZ. Tumour Biol; 2011 Feb; 32(1):215-22. PubMed ID: 20878561 [Abstract] [Full Text] [Related]
12. Genetic polymorphisms of CYP1A1, CYP2D6, GSTM1, and GSTT1 and susceptibility to acute lymphoblastic leukemia in Indian children. Aplenc R. Pediatr Blood Cancer; 2004 Oct; 43(5):539-41. PubMed ID: 15382269 [No Abstract] [Full Text] [Related]
13. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer. Sharma A, Mishra A, Das BC, Sardana S, Sharma JK. Neoplasma; 2006 Oct; 53(4):309-15. PubMed ID: 16830058 [Abstract] [Full Text] [Related]
15. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression. Duarte EC, Ribeiro DC, Gomez MV, Ramos-Jorge ML, Gomez RS. Anticancer Res; 2008 Oct; 28(2A):1101-6. PubMed ID: 18507060 [Abstract] [Full Text] [Related]
16. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome. Chacko P, Joseph T, Mathew BS, Rajan B, Pillai MR. Mutat Res; 2005 Mar 07; 581(1-2):153-63. PubMed ID: 15725614 [Abstract] [Full Text] [Related]
17. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K. Mutat Res; 2005 Jul 01; 574(1-2):112-23. PubMed ID: 15914211 [Abstract] [Full Text] [Related]
19. Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population. Silig Y, Pinarbasi H, Günes S, Ayan S, Bagci H, Cetinkaya O. Cancer Invest; 2006 Feb 01; 24(1):41-5. PubMed ID: 16466991 [Abstract] [Full Text] [Related]